Characteristics and healthcare resource utilisation (HRU) of patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) on enzalutamide (ENZ) or abiraterone acetate (AA) in England: PROCCO study

Merseburger A., Faria R.,Bahl A., Attard G., Snijder R., Sodatonou H., Pranzo A., Martins K., Rozario N., Flach C., Ridsdale-Smith J., Chilelli A.

European Urology Open Science（2023）

引用 0|浏览0

暂无评分

关键词

prostate cancer,abiraterone acetate,healthcare resource utilisation,castration-resistant

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要